Evidence map›Paper›PMID 40820811›Full record

ArticleHaematologica2026

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study.

Jung Yeon Lee, Seungpil Jung, Suein Choi, Sung-Soo Park, Jin Seok Kim, Je-Jung Lee, Seong Kyu Park, Hyo Jung Kim, Gyeong-Won Lee, Young Hoon Park and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jung Yeon LeeDepartment of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital.
Seungpil JungPharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Data Science, Catholic Research Network for Multiple Myeloma.
Suein ChoiPharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Data Science, Catholic Research Network for Multiple Myeloma.
Sung-Soo ParkDepartment of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul.
Jin Seok KimDivision of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital.
Je-Jung LeeDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do.
Seong Kyu ParkDepartment of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Seoul.
Hyo Jung KimDepartment of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang.
Gyeong-Won LeeDivision of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju.
Young Hoon ParkDivision of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Medical Center Mokdong Hospital, Seoul.
Hyeon-Seok EomDepartment of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang.
Jeong-A KimDepartment of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul.
Min Kyoung KimDivision of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea.
Yundeok KimDivision of Hemato-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital.
Ho-Jin ShinDivision of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan.
Ho Sup LeeDepartment of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan.
Jihyun KwonDepartment of Internal Medicine, Hematology and Oncology, Chungbuk National University, College of Medicine.
Chang-Ki MinDepartment of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul. ckmin@catholic.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40820811
PMCPMC12775751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.